Melanoma: open trials in Romania

9 open trials have a site in Romania. Registry data; only the trial team decides who can take part.

NCT07221734
Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] Melanoma
Trial Treatment · Phase 3 · mAbxience Research S.L.
Craiova
Registry updated 2026-10-29
2025-521919-39-00
A PK study to compare JPB898 (proposed nivolumab biosimilar) and US-licensed Opdivo® in participants with resected stage IIB, IIC, or III melanoma in the adjuvant setting
Trial Treatment · Phase 1 · H e x a l AG
Institutul Oncologic Prof. Dr. Alexandru Trestioreanu Bucuresti, Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca · Centrul De Oncologie SF Nectarie S.R.L., Craiova · Nova-Clin Medical Research Center S.R.L., Timisoara · Asociatia Oncohelp, Timișoara
Registry updated 2026-10-19
NCT07476326
Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma
Trial Treatment · Phase 1 · Biocon Biologics UK PLC
Institutul Oncologic Prof. Dr. Alexandru Trestioreanu Bucuresti, Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca · Centrul De Oncologie SF Nectarie S.R.L., Craiova
Registry updated 2026-09-25
NCT07475572
Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma
Trial Treatment · Phase 1 · Alvotech Swiss AG
Institutul Oncologic Prof. Dr. Alexandru Trestioreanu Bucuresti, Bucharest · Futuremeds S.R.L., Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca · Centrul De Oncologie SF Nectarie S.R.L., Craiova
Registry updated 2026-08-24
2025-521562-95-00
Randomised, Multicentre, Multinational, Double-Blind Integrated Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 (Proposed Nivolumab Biosimilar) Versus EU-/US-Opdivo in Subjects With Previously Untreated Advanced (Unresectable or Metastatic) Melanoma (LEON Study)
Trial Treatment · Phase 3 · Mabxience Research S.L.
Centrul De Oncologie SF Nectarie S.R.L., Craiova
Registry updated 2026-06-04
2025-524267-20-00
An open label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover bioequivalence study comparing Trametinib tablets 2 mg, Manufactured by Sun Pharmaceutical Industries Limited, India with MEKINIST® (Trametinib) tablets 2 mg, Distributed by: Novartis Pharmaceuticals Corporation, East Hanover, New Jersey 07936, USA in healthy, adult, human subjects under fasting condition.
Trial Treatment · Phase 1 · Sun Pharmaceutical Industries Limited
Terapia S.A., Cluj-Napoca
Registry updated 2026-04-30
2023-510017-26-00
A Double-Blind, Randomized, Three-arm, Active-Controlled, Parallel-Group, Phase 1 Study Evaluating Pharmacokinetic Similarity of Three Formulations of Pembrolizumab (CT-P51, EU-approved Keytruda, and US-licensed Keytruda) as Adjuvant Therapy in Patients with Completely Resected Stage IIB, IIC, and III Melanoma
Trial Treatment · Phase 1 · Celltrion Inc.
Institutul Oncologic Prof. Dr. Alexandru Trestioreanu Bucuresti, Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca · Centrul De Oncologie SF Nectarie S.R.L., Craiova
Registry updated 2026-04-20
NCT06112314
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Trial Treatment · Phase 3 · Immunocore Ltd
L'Institute Oncologique Prof. Dr. Ion Chiricuta (IOCN) (The Oncology Institute Prof. Dr. Ion. Chiricuta), Cluj-Napoca · Sf Nectarie Oncology Center, Craiova · Victoria Hospital (Centrul de oncologie Euroclinic SRL) (Centrul De Oncologie Medicala) (Euroclinic Onchology Center), Iași
Registry updated 2026-02-25
2025-522307-14-00
A Study to Evaluate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of Xdivane versus Opdivo® in Patients with Resected Melanoma
Trial Treatment · Phase 1 · Intas Pharmaceuticals Limited
Institutul Oncologic Prof. Dr. Alexandru Trestioreanu Bucuresti, Bucharest · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca · Centrul De Oncologie SF Nectarie S.R.L., Craiova
Registry updated 2026-02-13

All Melanoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error